
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, ... Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its lead product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a highly contagious and primarily pediatric viral skin disease, and common warts. 더 보기
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.0769 | -11.0567936736 | 0.6955 | 0.7099 | 0.576 | 428682 | 0.62523398 | CS |
4 | -0.0533 | -7.93272808454 | 0.6719 | 0.779 | 0.576 | 296546 | 0.67243721 | CS |
12 | -0.2429 | -28.1950087057 | 0.8615 | 0.8744 | 0.576 | 419940 | 0.68721388 | CS |
26 | -1.5115 | -70.9591099009 | 2.1301 | 2.1301 | 0.576 | 657043 | 1.11270942 | CS |
52 | -4.6114 | -88.17208413 | 5.23 | 11.41 | 0.576 | 528960 | 2.54434653 | CS |
156 | -7.6314 | -92.5018181818 | 8.25 | 11.41 | 0.576 | 407917 | 3.97707736 | CS |
260 | -11.2214 | -94.7753378378 | 11.84 | 18.42 | 0.576 | 284218 | 4.93568915 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관